LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 92.84 USD -1.28% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
LeMaitre Vascular Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one LMAT stock under the Base Case scenario is 65.8 USD. Compared to the current market price of 92.84 USD, LeMaitre Vascular Inc is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LMAT Relative Value
Base Case
65.8 USD
Overvaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.8
P/S
P/S
Price to Sales
9.8
vs History
0
vs Industry
14
Median 3Y
6.9
Median 5Y
6.8
Industry
2.3
Forward
9.3
More Details
50.5
P/E
P/E
Price to Earnings
50.5
vs History
6
vs Industry
7
Median 3Y
49
Median 5Y
43.6
Industry
23.2
Forward
46.8
More Details
52.6
P/OCF
P/OCF
Price to OCF
52.6
vs History
3
vs Industry
6
Median 3Y
39.9
Median 5Y
35.7
Industry
14.3
More Details
62.3
P/FCFE
P/FCFE
Price to FCFE
62.3
vs History
9
vs Industry
10
Median 3Y
51.2
Median 5Y
44.8
Industry
20.1
More Details
6.3
P/B
P/B
Price to Book Value
6.3
vs History
0
vs Industry
12
Median 3Y
4.3
Median 5Y
4.4
Industry
2.2
More Details
9.2
EV/S
EV/S
Enterprise Value to Sales
9.2
vs History
0
vs Industry
13
Median 3Y
6.4
Median 5Y
6.3
Industry
2.4
Forward
8.7
More Details
13.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.5
vs History
0
vs Industry
14
Median 3Y
9.8
Median 5Y
9.7
Industry
5
More Details
33.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.1
vs History
0
vs Industry
7
Median 3Y
25.8
Median 5Y
24.9
Industry
12.8
Forward
28.9
More Details
39.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.6
vs History
3
vs Industry
8
Median 3Y
32.8
Median 5Y
31.5
Industry
17.2
Forward
36.5
More Details
49.5
EV/OCF
EV/OCF
Enterprise Value to OCF
49.5
vs History
3
vs Industry
8
Median 3Y
36.7
Median 5Y
33.2
Industry
14
More Details
58.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
58.6
vs History
4
vs Industry
8
Median 3Y
43.2
Median 5Y
41.6
Industry
18.2
More Details
7.8
EV/IC
EV/IC
Enterprise Value to IC
7.8
vs History
0
vs Industry
11
Median 3Y
4.8
Median 5Y
4.7
Industry
1.9
More Details

Multiples Across Competitors

LMAT Competitors Multiples
LeMaitre Vascular Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
LeMaitre Vascular Inc
NASDAQ:LMAT
2.1B USD 9.8 50.5 33.1 39.6
US
Abbott Laboratories
NYSE:ABT
199.4B USD 4.8 34.6 20.1 29.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.5B USD 24.2 84.9 72.5 90
US
Stryker Corp
NYSE:SYK
139.9B USD 6.4 39 25.3 30.8
US
Boston Scientific Corp
NYSE:BSX
133.6B USD 8.4 74.5 34.2 48.8
IE
Medtronic PLC
NYSE:MDT
103.6B USD 3.1 24.1 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66B USD 3.3 38.3 15.8 28.3
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.6B USD 7.9 10.7 23.9 26.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
313.1B CNY 8.4 25.3 22 22
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.3B USD 1.9 21.7 13.6 16.7

See Also

Summary
LMAT intrinsic value, competitors valuation, and company profile.
DCF Valuation
LMAT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LMAT stock valuation using valuation multiples.
Wall Street Estimates
LMAT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LMAT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.